CVS Health Aktie News

Current CVS Health CEO David Joyner took over a little over a year ago. The company's growth rate has been improving and its overall financial results have been stronger.

WOONSOCKET, R.I. , Nov. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold its Investor Day on December 9 th, 2025.

Skyrizi and Rinvoq sales are pushing AbbVie's sales higher. UnitedHealth Group raised its full-year guidance and is rebounding from a disastrous 2025.

CVS Health has improved its financial results this year. The company's efforts could allow it to maintain that momentum.

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the United States, replacing OneTouch® branded blood glucose monitors and test strips. The TRUE METRIX® portfolio delivers scientifically backed perfor...

CVS Health offers a compelling value and income opportunity, trading at a forward P/E under 12 with a 3.4% dividend yield. It delivered strong Q3 results, driven by Aetna's insurance segment and momentum in transparent PBM pricing via CostVantage. Management raised 2025 EPS guidance, projecting robust double-digit earnings growth. It also has a well-covered, growing dividend.

WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America.

I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, attractive yields, reasonable payout ratios, and a proven record or potential for dividend growth. CVX and ARCC receive positive Wall Street ratings, while VZ and MO offer high yields and strong fre...